Outside the Guidelines: Denosumab Overuse in Prostate Cancer – Medscape
Many men with castration-sensitive prostate cancer receive the bone-modifying agent to prevent skeletal-related events, but that practice is not …
08/25/2026
Many men with castration-sensitive prostate cancer receive the bone-modifying agent to prevent skeletal-related events, but that practice is not …